Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 2/20 | 0.37 |
| ▸ | ANPEP | P15144 | 1/20 | 0.37 |
| ▸ | KDM4A | O75164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7798930 | 0.92 | F10 (0.42) | POLBCA2CA1CYP2D6CYP2C9 | |
| SCHEMBL7793421 | 0.88 | POLB (0.43) | POLBCA2CA1CYP2D6CYP2C9 | |
| SCHEMBL7803203 | 0.83 | POLB (0.51) | POLBCA2CA1CYP2D6CYP2C9 | |
| SCHEMBL7793442 | 0.79 | POLB (0.43) | POLBCA2CA1KMT2ACA5A | |
| SCHEMBL7799269 | 0.79 | MTNR1A (0.45) | POLBCA2CA1CA5AMMP8 | |
| SCHEMBL7798918 | 0.78 | POLB (0.42) | POLBCA2CA1CYP2D6CYP2C9 | |
| SCHEMBL7793398 | 0.78 | L3MBTL1 (0.46) | POLBCA2KMT2A | |
| SCHEMBL7798895 | 0.75 | NPC1 (0.50) | KMT2AMMP8 | |
| SCHEMBL7802324 | 0.75 | ITGB3 (0.48) | — | |
| SCHEMBL7793404 | 0.74 | F10 (0.48) | POLBCA2CA1CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1143960-A2 | CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES | Roche Diagnostics GmbH (DE) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000027378-A2 | CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES | ROCHE DIAGNOSTICS GMBH (DE) | 2000-05-18 | — | — | WO | disclosed |